These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 25203323)

  • 41. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo.
    Markus MA; Heinrich B; Raitskin O; Adams DJ; Mangs H; Goy C; Ladomery M; Sperling R; Stamm S; Morris BJ
    Exp Cell Res; 2006 Oct; 312(17):3379-88. PubMed ID: 16934801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.
    Sheng J; Zhao Q; Zhao J; Zhang W; Sun Y; Qin P; Lv Y; Bai L; Yang Q; Chen L; Qi Y; Zhang G; Zhang L; Gu C; Deng X; Liu H; Meng S; Gu H; Liu Q; Coulson JM; Li X; Sun B; Wang Y
    EBioMedicine; 2018 Dec; 38():113-126. PubMed ID: 30429088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
    Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Comprehensive Prognostic and Immune Infiltration Analysis of RBM4 in Pan-Cancer.
    Ding JJ; Wu J; Bian HL; Zong Y; Lu B; Ni L
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):89. PubMed ID: 38420804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nrf2/p62 signaling in apoptosis resistance and its role in cadmium-induced carcinogenesis.
    Son YO; Pratheeshkumar P; Roy RV; Hitron JA; Wang L; Zhang Z; Shi X
    J Biol Chem; 2014 Oct; 289(41):28660-75. PubMed ID: 25157103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phylogenetic and molecular characterization of the splicing factor RBM4.
    Lu CC; Chen TH; Wu JR; Chen HH; Yu HY; Tarn WY
    PLoS One; 2013; 8(3):e59092. PubMed ID: 23527094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
    Zhu S; Chen W; Wang J; Qi L; Pan H; Feng Z; Tian D
    Theranostics; 2021; 11(7):3359-3375. PubMed ID: 33537092
    [No Abstract]   [Full Text] [Related]  

  • 49. Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo.
    Li Y; Ma C; Qian M; Wen Z; Jing H; Qian D
    Oncol Rep; 2014 Mar; 31(3):1271-6. PubMed ID: 24452698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
    Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing.
    Mao S; Li Y; Lu Z; Che Y; Huang J; Lei Y; Wang Y; Liu C; Wang X; Zheng S; Sun N; He J
    Cancer Med; 2019 May; 8(5):2429-2441. PubMed ID: 30932358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
    Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
    Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alternative splicing of S6K1 promotes non-small cell lung cancer survival.
    Mei H; Wang Y; Fan J; Lin Z
    Tumour Biol; 2016 Oct; 37(10):13369-13376. PubMed ID: 27460085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion.
    Kar A; Havlioglu N; Tarn WY; Wu JY
    J Biol Chem; 2006 Aug; 281(34):24479-88. PubMed ID: 16777844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells.
    Zhou X; Li X; Cheng Y; Wu W; Xie Z; Xi Q; Han J; Wu G; Fang J; Feng Y
    Nat Commun; 2014 Aug; 5():4581. PubMed ID: 25091051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
    Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
    BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell stress modulates the function of splicing regulatory protein RBM4 in translation control.
    Lin JC; Hsu M; Tarn WY
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2235-40. PubMed ID: 17284590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression.
    Ezponda T; Pajares MJ; Agorreta J; Echeveste JI; López-Picazo JM; Torre W; Pio R; Montuenga LM
    Clin Cancer Res; 2010 Aug; 16(16):4113-25. PubMed ID: 20682707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of Mcl-1 by SRSF1 and SRSF5 in cancer cells.
    Gautrey HL; Tyson-Capper AJ
    PLoS One; 2012; 7(12):e51497. PubMed ID: 23284704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevation of EIF4G1 promotes non-small cell lung cancer progression by activating mTOR signalling.
    Lu Y; Yu S; Wang G; Ma Z; Fu X; Cao Y; Li Q; Xu Z
    J Cell Mol Med; 2021 Mar; 25(6):2994-3005. PubMed ID: 33523588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.